MARROW TRANSPLANTATION FOR MALIGNANT DISEASE

被引：14

作者：

THOMAS, ED

机构：

[1] UNIV WASHINGTON,SCH MED,SEATTLE,WA 98195

[2] FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104

来源：

AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 1987年 / 294卷 / 02期

关键词：

D O I：

10.1097/00000441-198708000-00003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：75 / 79

页数：5

共 32 条

[1] REVIEW OF THE USE OF MARROW TRANSPLANTATION IN THE TREATMENT OF NON-HODGKINS LYMPHOMA [J].

APPELBAUM, FR ;

THOMAS, ED .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (07) :440-447

[2] ALLOGENEIC MARROW TRANSPLANTATION IN THE TREATMENT OF MOPP-RESISTANT HODGKINS-DISEASE [J].

APPELBAUM, FR ;

SULLIVAN, KM ;

THOMAS, ED ;

BUCKNER, CD ;

CLIFT, RA ;

DEEG, HJ ;

NEIMAN, PE ;

SANDERS, JE ;

STEWART, P ;

STORB, R .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) :1490-1494

[3] BONE-MARROW TRANSPLANTATION OR CHEMOTHERAPY AFTER REMISSION INDUCTION FOR ADULTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA - A PROSPECTIVE COMPARISON [J].

APPELBAUM, FR ;

DAHLBERG, S ;

THOMAS, ED ;

BUCKNER, CD ;

CHEEVER, MA ;

CLIFT, RA ;

CROWLEY, J ;

DEEG, HJ ;

FEFER, A ;

GREENBERG, PD ;

KADIN, M ;

SMITH, W ;

STEWART, P ;

SULLIVAN, K ;

STORB, R ;

WEIDEN, P .

ANNALS OF INTERNAL MEDICINE, 1984, 101 (05) :581-588

[4]

APPERLEY JF, 1986, BLOOD S, V68, pA270

[5] MARROW TRANSPLANTATION FROM RELATED DONORS OTHER THAN HLA-IDENTICAL SIBLINGS [J].

BEATTY, PG ;

CLIFT, RA ;

MICKELSON, EM ;

NISPEROS, BB ;

FLOURNOY, N ;

MARTIN, PJ ;

SANDERS, JE ;

STEWART, P ;

BUCKNER, CD ;

STORB, R ;

THOMAS, ED ;

HANSEN, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (13) :765-771

[6]

BLUME KG, 1985, BLOOD, V66, P1488

[7] INCREASING UTILIZATION OF BONE-MARROW TRANSPLANTATION [J].

BORTIN, MM ;

RIMM, AA .

TRANSPLANTATION, 1986, 42 (03) :229-234

[8] BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA - FACTORS ASSOCIATED WITH EARLY MORTALITY [J].

BORTIN, MM ;

GALE, RP ;

KAY, HEM ;

RIMM, AA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (09) :1166-1175

[9] CYTOMEGALOVIRUS IMMUNE GLOBULIN AND SERONEGATIVE BLOOD PRODUCTS TO PREVENT PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION [J].

BOWDEN, RA ;

SAYERS, M ;

FLOURNOY, N ;

NEWTON, B ;

BANAJI, M ;

THOMAS, ED ;

MEYERS, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (16) :1006-1010

[10] TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A PROSPECTIVE CONTROLLED TRIAL OF BONE-MARROW TRANSPLANTATION VERSUS CONSOLIDATION CHEMOTHERAPY [J].

CHAMPLIN, RE ;

HO, WG ;

GALE, RP ;

WINSTON, D ;

SELCH, M ;

MITSUYASU, R ;

LENARSKY, C ;

ELASHOFF, R ;

ZIGHELBOIM, J ;

FEIG, SA .

ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) :285-291

← 1 2 3 4 →